Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Chiesi-Group"

3 News Found

FDA okays JUXTAPID for kids with ultra-rare genetic cholesterol disorder
News | March 06, 2026

FDA okays JUXTAPID for kids with ultra-rare genetic cholesterol disorder

Chiesi inks agreement with AbbVie subsidiary to push next-generation brain-targeting therapies for rare diseases
News | November 19, 2025

Chiesi inks agreement with AbbVie subsidiary to push next-generation brain-targeting therapies for rare diseases

Chiesi Farmaceutici completes acquisition of Amryt Pharma
News | April 15, 2023

Chiesi Farmaceutici completes acquisition of Amryt Pharma

Acquisition positions Chiesi to expand patient access to approved treatments and advance efforts to develop new treatments for people living with rare diseases.

Upcoming E-conference
June 19, 2026 The Future of Clinical Research in India: Can India Become a Global Trial Hub?
July 17, 2026 Biosimilars & Biologics: The Next Growth Frontiers for Indian Pharma

Latest Stories

Lonza and Stipple Bio partner to advance next-generation precision oncology ADC therapies

Aurobindo Pharma receives USFDA nod for generic Tofacitinib tablets

Suven Life reports positive interim review for phase 3 Alzheimer’s therapy

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
India’s medical devices sector is poised for a pharma-like transformation: Pranav Sharma, SBU Head - Advanced Surgery, Healthium MedTech
India’s medical devices sector is poised for a pharma-like transformation: Pranav Sharma, SBU Head - Advanced Surgery, Healthium MedTech
Pranav Sharma Strategic Business Unit Head - Advance Surgery, Healthium MedTech
Expanding our technical portfolio with advanced ICP-OES Series to boost India's analytical capabilities: Santosh Kumar, Managing Director, Analytik Jena India
Expanding our technical portfolio with advanced ICP-OES Series to boost India's analytical capabilities: Santosh Kumar, Managing Director, Analytik Jena India
Empowering life sciences and diagnostics with balanced, scalable technologies: Dev Ananthan, Director of Strategic Marketing, Danaher Lifesciences
Empowering life sciences and diagnostics with balanced, scalable technologies: Dev Ananthan, Director of Strategic Marketing, Danaher Lifesciences

Packaging